NLM Digital Collections

Search

Start Over Subjects United States ✖Remove constraint Subjects: United States Publication Year 2017 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2017">2017</span>

133. Designing a high-performance health care system for patients with complex needs: ten recommendations for policymakers : expanded and revised edition

Publication:
[New York, N.Y.] : Commonwealth Fund, September 2017
Subject(s):
Delivery of Health Care, Integrated
Health Expenditures
Health Services Needs and Demand
Caregivers
Comorbidity
Mental Health Services
Reimbursement Mechanisms
Patient Participation
Social Support
Humans
Canada
England
France
Israel
Netherlands
Spain
Sweden
United States

134. Health care improvement in Pueblo, Colorado: building on common ground

Author(s):
Hostetter, Martha, author
Klein, Sarah, author
McCarthy, Douglas, author
Publication:
[New York, N.Y.] : Commonwealth Fund, September 2017
Subject(s):
Delivery of Health Care, Integrated
Health Care Coalitions
Interinstitutional Relations
Quality Indicators, Health Care
Quality of Health Care
Health Policy
Health Services Accessibility -- statistics & numerical data
Hispanic Americans
Hospitalization -- statistics & numerical data
Medicaid
Preventive Health Services -- statistics & numerical data
State Government
Humans
Colorado
United States

135. Emergency use authorization of medical products and related authorities: guidance for industry and other stakeholders

Publication:
Silver Spring, MD : Food and Drug Administration, U.S. Department of Health and Human Services, January 2017
Subject(s):
Civil Defense -- legislation & jurisprudence
Device Approval
Drug Approval
Emergencies
Terrorism
Emergency Medical Services
Equipment Safety
Off-Label Use
Public Health
Safety
Humans
United States
United States. Department of Health and Human Services.
United States. Department of Homeland Security.
United States. Food and Drug Administration.

136. Form FDA 3674--certifications to accompany drug, biological product, and device applications/submissions: guidance for sponsors, industry, researchers, investigators, and food and drug administration staff

Publication:
Silver Spring, MD : Food and Drug Administration, U.S. Department of Health and Human Services, June 2017
Subject(s):
Device Approval
Drug Approval
Investigational New Drug Application
Access to Information
Clinical Trials as Topic
Drugs, Investigational
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

137. E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs--questions and answers (R3)

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, June 2017
Subject(s):
Arrhythmias, Cardiac -- chemically induced
Arrhythmias, Cardiac -- diagnosis
Cardiac Electrophysiology -- methods
Cardiac Electrophysiology -- standards
Drug Approval
Electrocardiography -- standards
Long QT Syndrome -- chemically induced
Cardiotoxins
Clinical Trials as Topic
Congresses as Topic
Diagnosis, Computer-Assisted
Drug-Related Side Effects and Adverse Reactions
International Cooperation
Pharmaceutical Preparations -- administration & dosage
Reference Standards
Research Design
Sex Factors
Humans
Europe
Japan
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

139. IRB waiver or alteration of informed consent for clinical investigations involving no more than minimal risk to human subjects: guidance for sponsors, investigators, and institutional review boards

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, July 2017
Subject(s):
Clinical Trials as Topic -- standards
Human Experimentation -- standards
Informed Consent -- standards
Ethics Committees, Research
Ethics, Research
Informed Consent -- ethics
Research Subjects
Risk
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.